271 related articles for article (PubMed ID: 31711450)
41. The role of microbiota in respiratory health and diseases, particularly in tuberculosis.
Shah T; Shah Z; Baloch Z; Cui X
Biomed Pharmacother; 2021 Nov; 143():112108. PubMed ID: 34560539
[TBL] [Abstract][Full Text] [Related]
42. Gut microbiome and metabolome alterations in traditional Chinese medicine damp-heat constitution following treatment with a Chinese patent medicine and lifestyle intervention.
Chen J; Cheng J; Li F; Deng Y; Li Y; Li H; Zeng J; You Y; Zhou X; Chen Q; Luo R; Lai Y; Zhao X
Phytomedicine; 2024 Aug; 131():155787. PubMed ID: 38851100
[TBL] [Abstract][Full Text] [Related]
43. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.
Khan MY; Kinsara AJ; Osoba AO; Wali S; Samman Y; Memish Z
Int J Antimicrob Agents; 2001 May; 17(5):415-8. PubMed ID: 11337231
[TBL] [Abstract][Full Text] [Related]
44. Diversity of Mycobacterium tuberculosis and drug resistance in different provinces of Papua New Guinea.
Ley SD; Harino P; Vanuga K; Kamus R; Carter R; Coulter C; Pandey S; Feldmann J; Ballif M; Siba PM; Phuanukoonnon S; Gagneux S; Beck HP
BMC Microbiol; 2014 Dec; 14():307. PubMed ID: 25476850
[TBL] [Abstract][Full Text] [Related]
45. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.
Buelow E; Bello González TDJ; Fuentes S; de Steenhuijsen Piters WAA; Lahti L; Bayjanov JR; Majoor EAM; Braat JC; van Mourik MSM; Oostdijk EAN; Willems RJL; Bonten MJM; van Passel MWJ; Smidt H; van Schaik W
Microbiome; 2017 Aug; 5(1):88. PubMed ID: 28803549
[TBL] [Abstract][Full Text] [Related]
46. Characterization of gut microbiota in children with pulmonary tuberculosis.
Li W; Zhu Y; Liao Q; Wang Z; Wan C
BMC Pediatr; 2019 Nov; 19(1):445. PubMed ID: 31735171
[TBL] [Abstract][Full Text] [Related]
47. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study.
Azad MB; Konya T; Persaud RR; Guttman DS; Chari RS; Field CJ; Sears MR; Mandhane PJ; Turvey SE; Subbarao P; Becker AB; Scott JA; Kozyrskyj AL;
BJOG; 2016 May; 123(6):983-93. PubMed ID: 26412384
[TBL] [Abstract][Full Text] [Related]
48. The Gut Microbiome Signatures Discriminate Healthy From Pulmonary Tuberculosis Patients.
Hu Y; Feng Y; Wu J; Liu F; Zhang Z; Hao Y; Liang S; Li B; Li J; Lv N; Xu Y; Zhu B; Sun Z
Front Cell Infect Microbiol; 2019; 9():90. PubMed ID: 31001490
[TBL] [Abstract][Full Text] [Related]
49. Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
Verbeeck RK; Günther G; Kibuule D; Hunter C; Rennie TW
Eur J Clin Pharmacol; 2016 Aug; 72(8):905-16. PubMed ID: 27305904
[TBL] [Abstract][Full Text] [Related]
50. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
Pang Y; Zhu D; Zheng H; Shen J; Hu Y; Liu J; Zhao Y
BMC Infect Dis; 2017 Nov; 17(1):711. PubMed ID: 29110640
[TBL] [Abstract][Full Text] [Related]
51. Specific class of intrapartum antibiotics relates to maturation of the infant gut microbiota: a prospective cohort study.
Coker MO; Hoen AG; Dade E; Lundgren S; Li Z; Wong AD; Zens MS; Palys TJ; Morrison HG; Sogin ML; Baker ER; Karagas MR; Madan JC
BJOG; 2020 Jan; 127(2):217-227. PubMed ID: 31006170
[TBL] [Abstract][Full Text] [Related]
52. Gut microbiota characteristics of Mongolian and Han populations in anti-tuberculosis drug-induced liver injury: a population-based case-control study.
Hao J; Li Y; Yu Y; Zheng L; Feng F
BMC Microbiol; 2023 Mar; 23(1):74. PubMed ID: 36927469
[TBL] [Abstract][Full Text] [Related]
53. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
[TBL] [Abstract][Full Text] [Related]
54. Living-donor liver transplantation in patients with concurrent active tuberculosis at transplantation.
Lee YT; Hwang S; Lee SG; Kim KW; Choi NK; Park GC; Yu YD; Yoo JW; Kim WS; Shim TS
Int J Tuberc Lung Dis; 2010 Aug; 14(8):1039-44. PubMed ID: 20626950
[TBL] [Abstract][Full Text] [Related]
55. Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study.
Nagu TJ; Aboud S; Matee MI; Maeurer MJ; Fawzi WW; Mugusi F
J Antimicrob Chemother; 2017 Mar; 72(3):876-881. PubMed ID: 27999054
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.
Swaminathan S; Narendran G; Venkatesan P; Iliayas S; Santhanakrishnan R; Menon PA; Padmapriyadarsini C; Ramachandran R; Chinnaiyan P; Suhadev M; Sakthivel R; Narayanan PR
Am J Respir Crit Care Med; 2010 Apr; 181(7):743-51. PubMed ID: 19965813
[TBL] [Abstract][Full Text] [Related]
57. Microbiome-immune interactions in tuberculosis.
Mori G; Morrison M; Blumenthal A
PLoS Pathog; 2021 Apr; 17(4):e1009377. PubMed ID: 33857251
[TBL] [Abstract][Full Text] [Related]
58. Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis.
García-Rodríguez JF; Valcarce-Pardeiro N; Álvarez-Díaz H; Mariño-Callejo A
Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2121-2126. PubMed ID: 31377953
[TBL] [Abstract][Full Text] [Related]
59. The altered gut microbiota in adults with cystic fibrosis.
Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
[TBL] [Abstract][Full Text] [Related]
60. Tuberculosis recurrence over a 7-year follow-up period in successfully treated patients in a routine program setting in China: a prospective longitudinal study.
Lin Y; Lin H; Xiao L; Chen Y; Meng X; Zeng X; Chang C; Brigden G
Int J Infect Dis; 2021 Sep; 110():403-409. PubMed ID: 34332089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
